Transit-oriented, mixed-use projects are in demand in the emerging post-pandemic economy of 2022, and the life-sciences sector thus far has maintained its momentum as a driver for growth.
A $2.8B mixed-use development moving forward in a growing transit hub in the middle of Long Island is aiming for the sweet spot of this trifecta of growth trends.
JLL is spearheading a public-private partnership that plans to build Midway Crossing, a 2.7M SF project in Ronkonkoma, NY—about 50 miles east of NYC—that will be anchored by a life sciences hub including medical research and health care facilities along with a STEM educational institute.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
